Health Care [ 9/12 ] | Biotechnology [ 38/73 ]
NASDAQ | Common Stock
Gain Therapeutics, Inc., a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas in Switzerland, Spain, the United States, and Australia.
Its drug discovery platform Magellan discovers novel allosteric binding sites in a disease; identifies proprietary small molecules that bind these sites to modulate protein function; and treats the underlying cause of the disease.
The company's lead drug candidate is GT-02287, which is currently in a Phase 1b study for the treatment of Parkinson's disease with or without a GBA1 mutation.
It has various small molecule drug candidates, which are in the discovery, research, and preclinical stages for the treatment of dementia with Lewy bodies, Alzheimer's disease, and Gaucher's disease, lysosomal storage disorders, metabolic disorders, and solid tumors.
Gain Therapeutics, Inc. was founded in 2017 and is based in Bethesda, Maryland.
Reported date | EPSChange YoY | EstimateSurprise |
---|---|---|
May 12, 25 | -0.16 Increased by +27.27% | -0.18 Increased by +11.11% |
Mar 24, 25 | -0.08 Increased by +77.78% | -0.19 Increased by +57.33% |
Nov 12, 24 | -0.17 Increased by +54.05% | -0.21 Increased by +19.05% |
Aug 8, 24 | -0.42 Increased by +32.26% | -0.20 Decreased by -110.00% |
May 14, 24 | -0.22 Increased by +48.84% | -0.29 Increased by +24.14% |
Mar 26, 24 | -0.36 Increased by +7.69% | -0.32 Decreased by -12.50% |
Nov 14, 23 | -0.37 Increased by +2.63% | -0.45 Increased by +17.78% |
Aug 10, 23 | -0.62 Decreased by -44.19% | -0.31 Decreased by -100.00% |
Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
---|---|---|---|
Mar 31, 25 | 0.00 Decreased by N/A% | -4.53 M Decreased by -12.85% | Decreased by N/A% Decreased by N/A% |
Dec 31, 24 | 0.00 Decreased by -100.00% | -3.77 M Increased by +20.23% | Decreased by N/A% Decreased by N/A% |
Sep 30, 24 | 0.00 Decreased by N/A% | -4.49 M Increased by +4.93% | Decreased by N/A% Decreased by N/A% |
Jun 30, 24 | 0.00 Decreased by N/A% | -8.14 M Decreased by -5.92% | Decreased by N/A% Decreased by N/A% |
Mar 31, 24 | 0.00 Decreased by -100.00% | -4.01 M Increased by +21.86% | Decreased by N/A% Decreased by N/A% |
Dec 31, 23 | 64.80 K Decreased by -53.75% | -4.72 M Decreased by -1.06% | Decreased by -7.29 K% Decreased by -118.51% |
Sep 30, 23 | 0.00 Decreased by N/A% | -4.72 M Decreased by -3.51% | Decreased by N/A% Decreased by N/A% |
Jun 30, 23 | 0.00 Decreased by -100.00% | -7.69 M Decreased by -51.18% | Decreased by N/A% Decreased by N/A% |